James R. Gruber insider trades
Open-market stock purchases and sales by James R. Gruber, Chief Financial Officer at Eton Pharmaceuticals, Inc, from SEC Form 4 filings since Jul 12, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 14, 2026 | ETON Eton Pharmaceuticals, Inc | Sold (not open market) | $35.5K |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 12, 2026 | ETON Eton Pharmaceuticals, Inc | Bought (not open market) | — |
| Dec 12, 2025 | ETON Eton Pharmaceuticals, Inc | Sold (not open market) | $77.2K |
| Dec 11, 2025 | ETON Eton Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- ETON Eton Pharmaceuticals, Inc: 2 sales, last Jan 14, 2026